Temporal trends in patient characteristics and outcomes among medicare beneficiaries undergoing primary prevention implantable cardioverter- defibrillator placement in the United States, 2006-2010: Results from the national cardiovascular data registry's implantable cardioverter-defibrillator registry

Circulation

Volumn 130, Issue 10, 2014, Pages 845-853

  Borne, Ryan T ^a   Peterson, Pamela N ^a,b,c   Greenlee, Robert ^d   Heidenreich, Paul A ^e   Wang, Yongfei ^f   Curtis, Jeptha P ^f   Tzou, Wendy S ^a   Varosy, Paul D ^a,c,g   Kremers, Mark S ^h   Masoudi, Frederick A ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Colorado Cardiovascular Outcomes Research ^*  (United States)

^d MARSHFIELD CLINIC   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VA Eastern Colorado Healthcare System   (United States)

^h Novant Health Heart Vascular Institute   (United States)

Author keywords

Implantable cardioverter defibrillators; Outcomes research; Quality; Registries

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COHORT ANALYSIS; COMORBIDITY; DEVICE FAILURE; DEVICE INFECTION; FEMALE; HEALTH CARE UTILIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL EDUCATION; MEDICAL FEE; MEDICARE; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PERICARDIOCENTESIS; PNEUMOTHORAX; PRIMARY PREVENTION; PRIORITY JOURNAL; UNITED STATES;

IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; OUTCOMES RESEARCH; QUALITY; REGISTRIES;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEE-FOR-SERVICE PLANS; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MEDICARE; PATIENT READMISSION; PRIMARY PREVENTION; REGISTRIES; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84907337111     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.008653     Document Type: Article

References (40)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
2. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO; American College of Cardiology/American Heart Association Task Force on Practice (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51:e1-e62.
5. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NAM 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2012;126:1784-1800.
6. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter- defibrillator. JAMA. 2009;301:1661-1670.
7. Dodson JA, Lampert R, Wang Y, Hammill SC, Varosy PD, Curtis JP. Temporal trends in quality of care among ICD recipients: Insights from the NCDR. Circulation. 2013 Nov Epub ahead of print]; PMID 24192798
8. Hammill S, Phurrough S, Brindis R. The National ICD Registry: now and into the future. Heart Rhythm. 2006;3:470-473.
9. Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010;7:1340-1345.
10. Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Meisnere LB, Conyers DM, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Walsh MN, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013;10:e59-e65.
11. Messenger JC, Ho KK, Young CH, Slattery LE, Draoui JC, Curtis JP, Dehmer GJ, Grover FL, Mirro MJ, Reynolds MR, Rokos IC, Spertus JA, Wang TY, Winston SA, Rumsfeld JS, Masoudi FA; NCDR Science and Quality Oversight Committee Data Quality Workgroup. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. J Am Coll Cardiol. 2012;60:1484-1488.
12. Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J. 2009;157:995-1000.
13. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender differences in procedure-related adverse events in patients receiving implantable cadioverter-defibrillator therapy. Circulation. 2009;119:1078-1084.
14. Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol. 2008;22:65-70.
15. Copie X, Piot O, Said MA, Lavergne T, Ollitrault J, Guize L, Le Heuzey JY. Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998. Pace. 2000;23:979-984.
16. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013;368:1210-1219.
17. Murad MH, Shahrour A, Shah ND, Montori VM, Ricotta JJ. A systematic review and meta-analysis of randomized trials of carotid endarterectomy vs stenting. J Vasc Surg. 2011;53:792-797.
18. Al-Khatib SM, Hellkamp A, Curtis J, Mark D, Peterson E, Sanders GD, Heidenreich PA, Hernandez AF, Curtis LH, Hammill S. Non-evidencebased ICD implantations in the United States. JAMA. 2011;305:43-49.
19. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517-1524.
20. Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006;119:167.e17-167.e21.
21. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525-1532.
22. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter- defibrillator racial disparity: the importance of geography. J Am Coll Cardiol. 2005;45:72-78.
23. Eapen ZJ, Al-Khatib S, Lopes RD, Wang Y, Bao H, Curtis J, Heidenreich PA, Hernandez AF, Peterson ED, Hammill SC. Are racial/ethnic gaps in the use of cardiac resynchroniziation therapy narrowing? J Am Coll Cardiol. 2012;60:1577-1578.
24. Farmer SA, Kirkpatrick JN, Heidenreich PA, Curtis JP, Wang Y, Groeneveld PW. Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm. 2009;6:325-331.
25. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care. 2005;43:320-329.
26. Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA; NCDR. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? Am Heart J. 2009;158:224-229.
27. Curtis LH, Greiner MA, Hammill BG, Kramer JM, Whellan DJ, Schulman KA, Hernandez AF. Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med. 2008;168:2481-2488.
28. Kosiborod M, Lichtman JH, Heidenreich PA, Normand SLT, Wang Y, Brass LM, Krumholz HM. National trends in outcomes among elderly patients with heart failure. Am J Med. 2006;119:616.e1-e16.
29. Mehta PA, Dubrey SW, McIntyre HF, Walker DM, Hardman SM, Sutton GC, McDonagh TA, Cowie MR. Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK. Heart. 2009;95:1851-1856.
30. Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA. 2013;309:55-62.
31. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.
32. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344-350.
33. Barker WH, Mullooly JP, Getchell W. Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990- 1994. Circulation. 2006;113:799-805.
34. Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119:515-523.
35. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007;297:2502-2514.
36. Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol. 2011;58:1007-1013.
37. Cheng A, Wang Y, Curtis JP, Varosy PD. Acute lead dislodgements and inhospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. J Am Coll Cardiol. 2010;56:1651-1656.
38. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter- defibrillator. JAMA. 2009;301:1661-1670.
39. Estafanous FG, Loop FD, Higgins TL, Tekyi-Mensah S, Lytle BW, Cosgrove DM 3rd, Roberts-Brown M, Starr NJ. Increased risk and decreased morbidity of coronary artery bypass grafting between 1986 and 1994. Ann Thorac Surg. 1998;65:383-389.
40. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol. 2008;1:240-249.